Over-the-counter naproxen in rheumatology practice: scope and therapeutic benefits
Over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) contain a relatively low dose of their active ingredient and are intended for short-term use (for 3–5 days). They are effective and convenient in the treatment of musculoskeletal pain in many clinical situations in rheumatology practice....
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2020-11-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1078 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849242163357941760 |
|---|---|
| author | E. S. Filatova A. E. Karateev |
| author_facet | E. S. Filatova A. E. Karateev |
| author_sort | E. S. Filatova |
| collection | DOAJ |
| description | Over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) contain a relatively low dose of their active ingredient and are intended for short-term use (for 3–5 days). They are effective and convenient in the treatment of musculoskeletal pain in many clinical situations in rheumatology practice. Over-the-counter naproxen 275 mg has a proven analgesic efficacy, with its action duration of up to 12–15 hours after single-dose administration, and a favorable safety profile. It can be used successfully for the management of exacerbations of osteoarthritis, short-term episodes of pain with a stable course of autoimmune inflammatory rheumatic diseases, with acute nonspecific back pain and at the onset of periarticular soft tissue pathology. With allowance made for the national guidelines for the use of NSAIDs, this drug can be prescribed for a short time as an analgesic therapy in patients at high risk for cardiovascular events. It is of particular value for outpatient practice, since the patients can freely purchase and use it in accordance with the principles of responsible self-medication. |
| format | Article |
| id | doaj-art-e47cec17b0aa40258f540c8ff53594ec |
| institution | Kabale University |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2020-11-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-e47cec17b0aa40258f540c8ff53594ec2025-08-20T03:59:54ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2020-11-0114412513110.14412/1996-7012-2020-4-125-1312306Over-the-counter naproxen in rheumatology practice: scope and therapeutic benefitsE. S. Filatova0A. E. Karateev1V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyOver-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) contain a relatively low dose of their active ingredient and are intended for short-term use (for 3–5 days). They are effective and convenient in the treatment of musculoskeletal pain in many clinical situations in rheumatology practice. Over-the-counter naproxen 275 mg has a proven analgesic efficacy, with its action duration of up to 12–15 hours after single-dose administration, and a favorable safety profile. It can be used successfully for the management of exacerbations of osteoarthritis, short-term episodes of pain with a stable course of autoimmune inflammatory rheumatic diseases, with acute nonspecific back pain and at the onset of periarticular soft tissue pathology. With allowance made for the national guidelines for the use of NSAIDs, this drug can be prescribed for a short time as an analgesic therapy in patients at high risk for cardiovascular events. It is of particular value for outpatient practice, since the patients can freely purchase and use it in accordance with the principles of responsible self-medication.https://mrj.ima-press.net/mrj/article/view/1078nonsteroidal anti-inflammatory drugsnaproxennaproxen sodiumteraliv 275®efficiencysafetyrheumatic diseases |
| spellingShingle | E. S. Filatova A. E. Karateev Over-the-counter naproxen in rheumatology practice: scope and therapeutic benefits Современная ревматология nonsteroidal anti-inflammatory drugs naproxen naproxen sodium teraliv 275® efficiency safety rheumatic diseases |
| title | Over-the-counter naproxen in rheumatology practice: scope and therapeutic benefits |
| title_full | Over-the-counter naproxen in rheumatology practice: scope and therapeutic benefits |
| title_fullStr | Over-the-counter naproxen in rheumatology practice: scope and therapeutic benefits |
| title_full_unstemmed | Over-the-counter naproxen in rheumatology practice: scope and therapeutic benefits |
| title_short | Over-the-counter naproxen in rheumatology practice: scope and therapeutic benefits |
| title_sort | over the counter naproxen in rheumatology practice scope and therapeutic benefits |
| topic | nonsteroidal anti-inflammatory drugs naproxen naproxen sodium teraliv 275® efficiency safety rheumatic diseases |
| url | https://mrj.ima-press.net/mrj/article/view/1078 |
| work_keys_str_mv | AT esfilatova overthecounternaproxeninrheumatologypracticescopeandtherapeuticbenefits AT aekarateev overthecounternaproxeninrheumatologypracticescopeandtherapeuticbenefits |